Given that the DU145 tumor cell line was sensitive to the treatment with the PAbs generated by Mv-HER3, this tumor line was selected as a human model to evaluate the in vivo antitumor effect of the Mv-HER3-induced PAbs. Here, ERBB3 is linked to neoplasm.